1. Home
  2. TECX vs RYAM Comparison

TECX vs RYAM Comparison

Compare TECX & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$23.33

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Logo Rayonier Advanced Materials Inc.

RYAM

Rayonier Advanced Materials Inc.

N/A

Current Price

$6.96

Market Cap

580.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
RYAM
Founded
2019
1926
Country
United States
United States
Employees
N/A
2325
Industry
Paper
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
580.4M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
TECX
RYAM
Price
$23.33
$6.96
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
★ $76.63
N/A
AVG Volume (30 Days)
233.3K
★ 821.8K
Earning Date
11-05-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 40.70
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $1,466,397,000.00
Revenue This Year
N/A
$0.86
Revenue Next Year
N/A
$7.38
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$15.45
$5.38
52 Week High
$39.53
$11.85

Technical Indicators

Market Signals
Indicator
TECX
RYAM
Relative Strength Index (RSI) 33.51 30.71
Support Level $20.52 N/A
Resistance Level $30.80 $8.81
Average True Range (ATR) 1.39 0.37
MACD 0.11 -0.15
Stochastic Oscillator 27.11 14.43

Price Performance

Historical Comparison
TECX
RYAM

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.

Share on Social Networks: